| Description | Dectrekumab (QAX576), a humanized monoclonal antibody targeting IL-13, significantly reduces intraepithelial esophageal eosinophil counts and normalizes dysregulated esophageal disease-related transcripts in Eosinophilic esophagitis (EoE), offering sustained benefits. It is valuable for inflammation and immunology research [1]. |
| Synonyms | QAX576 |
| molecular weight | N/A |
| CAS | 1528523-94-5 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 years |